期刊文献+

基于NF-κB途径探讨溃疡性结肠炎发病机制及中药干预作用研究进展 被引量:3

Research Progress on Pathogenesis of Ulcerative Colitis and Intervention of Traditional Chinese Medicine Based on NF-κB Pathway
下载PDF
导出
摘要 溃疡性结肠炎(ulcerative colitis,UC)是一种非特异性、复发性的慢性肠道炎症性疾病,发病机制尚不明确。目前治疗药物以氨基水杨酸类、皮质类固醇、免疫抑制剂等为主,但对UC患者疗效欠佳,有些患者因不良反应加重了身体负担。近年来中药在治疗溃疡性结肠炎中疗效显著,且不良反应小,基于NF-κB信号通路对中药进一步深入治疗UC的文献进行综述,为中药治疗UC作用机制提供依据。 Ulcerative colitis(UC)is a nonspecific,recurrent chronic inflammatory disease of the intestine,and its pathogene⁃sis remains unclear.Currently,the main treatment drugs are aminosalicylic acid,corticosteroids,immunosuppressants and so on,but the efficacy is not good,and some patients have increased the burden of the body due to adverse reactions.In recent years,traditional Chinese medicine has a significant therapeutic effect in the treatment of UC,with little toxic and side effects.This pa⁃per reviewed the literature on the treatment of UC by traditional Chinese medicine based on NF-κB signaling pathway,providing evidence for the further study of the mechanism of traditional Chinese medicine in the treatment of UC.
作者 高飞云 刘婷 张转红 王彦钧 张育贵 孙宇靖 李越峰 GAO Feiyun;LIU Ting;ZHANG Zhuanhong;WANG Yanjun;ZHANGYugui;SUN Yujing;LI Yuefeng(Gansu University of Chinese Medicine,Lanzhou 730000,Gansu,China;Key Laboratory for The Study of Quality and Standards of Chinese Medicine in Gansu Province,Lanzhou 730000,Gansu,China;Research Center for Chinese Medicine and Pharmaceutical Technology Engineering,Lanzhou 730000,Gansu,China)
出处 《中华中医药学刊》 CAS 北大核心 2023年第6期123-127,共5页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学基金项目(82160750) 甘肃省自然科学基金创新基地和人才计划项目(18JR3RA197) 甘肃省中药质量与标准研究重点实验室开放基金项目(ZYZL18-008)。
关键词 溃疡性结肠炎 NF-ΚB信号通路 中药复方 中药活性成分 机制 中药干预 ulcerative colitis NF-κB signaling pathway Chinese medicine compound active ingredients of traditional Chi⁃nese medicine mechanism traditional Chinese medicine intervention
  • 相关文献

参考文献40

二级参考文献496

共引文献770

同被引文献42

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部